BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34764788)

  • 1. Relationship between Gd-IgA1 and TNFR1 in IgA nephropathy and IgA vasculitis nephritis in children - multicenter study.
    Mizerska-Wasiak M; Gajewski Ł; Cichoń-Kawa K; Siejko A; Małdyk J; Spława-Neyman A; Zachwieja J; Firszt-Adamczyk A; Stankiewicz R; Drożyńska-Duklas M; Żurowska A; Bieniaś B; Sikora P; Pukajło-Marczyk A; Zwolińska D; Szczepańska M; Pawlak-Bratkowska M; Tkaczyk M; Stelmaszczyk-Emmel A; Pańczyk-Tomaszewska M
    Cent Eur J Immunol; 2021; 46(2):199-209. PubMed ID: 34764788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA vasculitis with nephritis: update of pathogenesis with clinical implications.
    Hastings MC; Rizk DV; Kiryluk K; Nelson R; Zahr RS; Novak J; Wyatt RJ
    Pediatr Nephrol; 2022 Apr; 37(4):719-733. PubMed ID: 33818625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
    Tang M; Zhang X; Li X; Lei L; Zhang H; Ling C; Ni J; Lv J; Liu X; Chen X
    Clin Exp Nephrol; 2021 Jan; 25(1):37-43. PubMed ID: 32935202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Usefulness of Vanin-1 and Periostin as Markers of an Active Autoimmune Process or Renal Fibrosis in Children with IgA Nephropathy and IgA Vasculitis with Nephritis-A Pilot Study.
    Mizerska-Wasiak M; Płatos E; Cichoń-Kawa K; Demkow U; Pańczyk-Tomaszewska M
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
    Elíasdóttir S; Khramova A; Saeed A; Guron G; Boi R; Mölne J; Ebefors K; Nyström J
    BMC Nephrol; 2023 Jun; 24(1):160. PubMed ID: 37286948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience.
    Su Q; Liang Y; Wang N; Dou Z; Rong Z; Zhao X; Yu B; Wang Y; Wang X
    Turk J Med Sci; 2021 Oct; 51(5):2683-2689. PubMed ID: 34392671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
    PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children.
    Lv Y; Fu R; Peng XJ; Wang Y; Yin TT; Deng YQ
    BMC Pediatr; 2023 Aug; 23(1):423. PubMed ID: 37620917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
    Zhang X; Xie X; Shi S; Liu L; Lv J; Zhang H
    Nephrol Dial Transplant; 2020 Dec; 35(12):2117-2123. PubMed ID: 31377786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
    PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schönlein nephritis.
    Mizerska-Wasiak M; Gajewski Ł; Cichoń-Kawa K; Małdyk J; Dziedzic-Jankowska K; Leszczyńska B; Rybi-Szumińska A; Wasilewska A; Pukajło-Marczyk A; Zwolińska D; Bieniaś B; Sikora P; Szczepańska M; Stelmaszczyk-Emmel A; Górska E; Pańczyk-Tomaszewska M
    Cent Eur J Immunol; 2018; 43(2):162-167. PubMed ID: 30135628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis.
    Kaga H; Matsumura H; Saito A; Saito M; Abe F; Suzuki T; Dohmae N; Odaka M; Komatsuda A; Wakui H; Takahashi N
    Clin Proteomics; 2023 May; 20(1):21. PubMed ID: 37179321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1.
    Tang Y; Zhu Y; He H; Peng Y; Hu P; Wu J; Sun W; Liu P; Xiao Y; Xu X; Wei M
    Front Med (Lausanne); 2022; 9():944027. PubMed ID: 35872757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis.
    Wang Y; Wang H; Ma X; Zhu Z; Tian X; Fu R; Jia L
    BMC Nephrol; 2024 Jan; 25(1):35. PubMed ID: 38273279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of left renal vein entrapment with IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Wang F; Zhu H; Bao S; Qi H; Xu L; Liu X; Zhai C; Yang X; Wang R
    Ren Fail; 2022 Dec; 44(1):1519-1527. PubMed ID: 36069515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
    Suzuki H; Moldoveanu Z; Julian BA; Wyatt RJ; Novak J
    Kidney Int Rep; 2019 Dec; 4(12):1717-1724. PubMed ID: 31844808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy.
    Kim JS; Hwang HS; Lee SH; Kim YG; Moon JY; Kong JY; Jeong KH
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33158064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
    He H; Shen M; Tang Y; Sun W; Xu X
    Altern Ther Health Med; 2024 Jan; 30(1):419-425. PubMed ID: 37820669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
    Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis.
    Zeng Q; Wang WR; Li YH; Liang Y; Wang XH; Yan L; Yu RH
    Front Immunol; 2023; 14():1209394. PubMed ID: 37671165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.